Core Laboratories enable discoveries to expand prediction, diagnosis and treatment of disease.
Clinicians apply genetic and genomic knowledge directly to care for patients.
LMM bridges research and clinical medicine, translating novel discoveries into genetic tests and accelerating personalized medicine by using new molecular tests in patient care.
The ninth annual conference will take place November 6-7, 2013. This year's conference seeks to identify the challenges and drawbacks of the principles of personalized medicine and come up with solutions to these problems.
The program is intended to advance translational genomics by leveraging the Partners Biorepository and RPDR to identify biological markers that can be used as potential predictive tests.